ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,747Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 2094

$1.51M Total Retail Price of All Prescriptions

Rank: 23 out of 2094

744 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 744 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 744 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 17,487 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 697 669 1 1
LEVOTHYROXINE SODIUM 625 588 2 3
AMLODIPINE BESYLATE 588 571 3 2
FUROSEMIDE 432 422 4 6
PANTOPRAZOLE SODIUM 428 401 5 37
ATORVASTATIN CALCIUM 399 381 6 5
LOSARTAN POTASSIUM 388 347 7 17
DONEPEZIL HCL 380 370 8 20
METOPROLOL SUCCINATE 364 336 9 9
OMEPRAZOLE 348 301 10 4
OXYCODONE-ACETAMINOPHEN 289 276 S2 11 40
LISINOPRIL 288 266 12 7
DIOVAN 277 268 13 13
METOPROLOL TARTRATE 274 256 14 10
POTASSIUM CHLORIDE 257 239 15 24
HYDROCHLOROTHIAZIDE 245 213 16 12
WARFARIN SODIUM 242 241 17 11
ESCITALOPRAM OXALATE 241 236 18 46
FAMOTIDINE 235 221 19 34
MIRTAZAPINE 228 218 20 43
NAMENDA 225 225 21 32
CYMBALTA 220 199 22 61
ATENOLOL 195 188 23 21
ADVAIR DISKUS 186 150 24 36
AMOXICILLIN 182 170 25 147
NEXIUM 178 167 26 16
ZOLPIDEM TARTRATE 161 145 27 14
PRAVASTATIN SODIUM 159 149 28 18
CRESTOR 150 138 29 15
METFORMIN HCL 150 119 29 8
GLIPIZIDE 144 133 31 82
PAROXETINE HCL 142 142 32 77
LIPITOR 138 134 33 39
AZITHROMYCIN 137 116 34 27
PREDNISONE 133 125 35 54
CALCITONIN-SALMON 127 124 36 272
CITALOPRAM HBR 127 110 36 47
CARVEDILOL 124 121 38 19
SYNTHROID 124 124 38 44
CLOPIDOGREL 124 119 38 22
RAMIPRIL 124 109 38 48
SERTRALINE HCL 122 115 42 26
CIPROFLOXACIN HCL 120 115 43 81
FLUTICASONE PROPIONATE 112 101 44 41
TAMSULOSIN HCL 111 94 45 29
GALANTAMINE HBR 108 108 46 351
LOSARTAN-HYDROCHLOROTHIAZIDE 105 99 47 52
HYDRALAZINE HCL 104 99 48 89
LIDODERM 102 102 49 59
FLUOXETINE HCL 102 98 49 139
SUCRALFATE 98 82 51 277
JANUVIA 96 90 52 35
FENTANYL 96 94 S2 52 68
PLAVIX 96 93 52 38
ALPRAZOLAM 94 86 55 150
DIGOXIN 94 94 55 51
GABAPENTIN 94 81 55 23
AMOX TR-POTASSIUM CLAVULANATE 93 84 58 107
METHYLPREDNISOLONE 91 85 59 127
EXELON 89 89 60 111
CLONIDINE HCL 86 86 61 62
LOVAZA 85 71 62 53
DILTIAZEM 24HR CD 84 67 63 110
ISOSORBIDE MONONITRATE ER 84 82 63 57
TRAMADOL HCL 83 80 65 33
HYDROCODONE-ACETAMINOPHEN 78 63 S3 66 42
VESICARE 77 77 67 152
SINGULAIR 75 73 68 64
NIFEDIPINE ER 74 69 69 96
ENALAPRIL MALEATE 74 74 69 25
TRICOR 71 67 71 99
DIOVAN HCT 68 68 72 28
CLOTRIMAZOLE-BETAMETHASONE 66 66 73 91
SPIRIVA 65 43 74 60
LYRICA 65 65 74 85
DETROL LA 64 53 76 233
ALENDRONATE SODIUM 64 55 76 30
ALLOPURINOL 62 56 78 50
LEVOFLOXACIN 60 60 79 70
DEXILANT 60 48 79 124
OXYCONTIN 60 59 S2 79 98
ACETAMINOPHEN-CODEINE 59 46 S3 82 129
ZETIA 59 59 82 79
FLUOCINONIDE 56 55 84 238
QUETIAPINE FUMARATE 54 53 85 71
LEXAPRO 53 52 86 180
PROAIR HFA 52 27 87 45
NITROGLYCERIN PATCH 51 51 88 101
IPRATROPIUM-ALBUTEROL 50 50 89 92
OXYBUTYNIN CHLORIDE 50 50 89 224
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.